Maximum quantity allowed is 999
Please select the quantity
CAS RN: 129830-38-2 | Product Number: Y0018
Y 27632 Dihydrochloride

Purity: >98.0%(HPLC)
Synonyms:
- (1R,4r)-4-[(R)-1-Aminoethyl]-N-(pyridin-4-yl)cyclohexanecarboxamide Dihydrochloride
Product Documents:
Size | Unit Price | Shanghai | Tianjin | Japan* |
---|---|---|---|---|
50MG |
¥1,790.00
|
1 | Contact Us | Contact Us |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
Product Number | Y0018 |
Purity / Analysis Method ![]() |
>98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__4H__2__1N__3O·2HCl = 320.26 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Light Sensitive,Hygroscopic,Heat Sensitive |
CAS RN | 129830-38-2 |
Reaxys Registry Number | 9163222 |
PubChem Substance ID | 468593133 |
MDL Number | MFCD03490488 |
Specifications
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Water | max. 8.0 % |
NMR | confirm to structure |
Properties (reference)
Melting Point | 252 °C(dec.) |
Specific Rotation | +4.0° (C=1,MeOH) |
GHS
Related Laws:
Transport Information:
Customs Control Conditions (Q) |
Application
Y-27632: A Rho associated Coiled-Coil Forming Protein Serine/Threonine Kinase (ROCK) Inhibitor
Y-27632 is a cell-permeable and selective Rho associated coiled-coil forming protein serine/threonine kinase (ROCK) inhibitor.1-4) ROCK is a serine-threonine protein kinase that has been identified as a target protein for the small GTP-binding protein Rho. It has been reported that ROCK is involved in various physiological function, including smooth muscle contraction and changes in cell morphology. ROCK inhibitors are expected to be applied to stem cell research reagents as well as to agents for hypertension and glaucoma. Y-27632 also inhibits LRRK2 (Leucine-rich repeat kinase 2) -G2019S that is a promising therapeutic target for the treatment of Parkinson's disease.5,6) (The product is for research purpose only.)
References
- 1) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension
- 2) Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases
- 3) Use and properties of ROCK-specific inhibitor Y-27632 (a review)
- 4) A ROCK inhibitor permits survival of dissociated human embryonic stem cells
- 5) Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
- 6) Development of a high-throughput AlphaScreen assay measuring full-length LRRK2(G2019S) kinase activity using moesin protein substrate
Documents
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.